SCHEMBL5699729

SCHEMBL5699729

Nc1ccccc1/C=C/c1cccc2cc3ccccc3cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ KEAP1 Q14145 1/20 0.42
▸ MITF O75030 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ GAA P10253 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ RCE1 Q9Y256 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29661840 0.88 ALDH1A1 (0.49) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL22288258 0.88 ALDH1A1 (0.49) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL5058738 0.86 ALDH1A1 (0.47) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL5058743 0.86 ALDH1A1 (0.47) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL4947905 0.83 ALDH1A1 (0.38) ALDH1A1KMT2AHPGDRAB9AMEN1
SCHEMBL3932039 0.82 ALDH1A1 (0.58) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL27794704 0.81 CYP19A1 (0.50) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL9000377 0.79 ALDH1A1 (0.43) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL21786017 0.79 ALDH1A1 (0.50) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL51050 0.79 RELA (0.52) ALDH1A1KMT2ARAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 — — US claimed
US-6790975-B2 ORGANIC ELECTROLUMINESCENCE; CONDENSATION FROM A CORRESPONDING AMINOBENZALDEHYDE AND A PHOSPHONIC ESTER OR PHOSPHONIUM SALT; YELLOW TO RED LIGHT SONY CORPORATION (JP) 2004-09-14 — — US claimed
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-12-11 — — US claimed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 — — US claimed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US claimed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP claimed
EP-1090911-B1 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORP (JP) 2006-08-30 — — EP disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
EP-1191015-A4 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH SONY CORP (JP) 2005-12-14 — — EP disclosed
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 — — US disclosed
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 — — US disclosed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 — — US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP disclosed
WO-2001077065-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH SONY CORPORATION (JP) 2001-10-18 — — WO disclosed
JP-2001288377-A AMINOSTYRYLANTHRACENE COMPOUND AND INTERMEDIATE FOR SYNTHESIZING THE SAME, AND METHOD FOR PRODUCING THESE COMPOUNDS SONY CORP 2001-10-16 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 ALDH1A1 1220/4885KMT2A 1075/4885HPGD 1031/4885
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 ALDH1A1 847/4885KMT2A 1007/4885HPGD 1443/4885
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF AASDHPPT, AADAT, ALDH7A1 ALDH1A1 847/4885KMT2A 1007/4885HPGD 1443/4885
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, ALDH7A1, AGPAT5 ALDH1A1 1057/4885KMT2A 1548/4885HPGD 2207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback